Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin versus tamsulosin and placebo for symptoms of benign prostatic hyperplasia
2005-005665-11Phase 3Completed
- Sponsor
- Recordati SpA
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Silodosin, Tamsulosin and Placebo (3 arms). Primary endpoint: Change from baseline to endpoint in total International Prostate Symptom Score. Started Feb 2006; status: completed.
02
Drugs
silodosintamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2005-005665-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005665-11.